1. Report Introduction
2. Pulmonary Arterial Hypertension (PAH) Epidemiology Overview at a Glance
3. Market Share Distribution of Pulmonary Arterial Hypertension (PAH)
4. Disease Background and Overview: Pulmonary Arterial Hypertension (PAH)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Pulmonary Arterial Hypertension (PAH) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Pulmonary Arterial Hypertension (PAH) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
7.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
7.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
7.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
7.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
8.1.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
8.1.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
8.1.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
8.1.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
8.2.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
8.2.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
8.2.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
8.2.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
8.3.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
8.3.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
8.3.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
8.3.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
8.4.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
8.4.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
8.4.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
8.4.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
8.5.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
8.5.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
8.5.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
8.5.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
9.3. Sub-Type Specific cases of Pulmonary Arterial Hypertension (PAH)*
9.4. Sex- Specific Cases of Pulmonary Arterial Hypertension (PAH)*
9.5. Diagnosed Cases of Pulmonary Arterial Hypertension (PAH)
9.6. Treated Cases of Pulmonary Arterial Hypertension (PAH)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.